SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950116-01-500609
Filing Date
2001-08-08
Accepted
2001-08-08 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 s3.txt S-3 85920
3 EXHIBIT 4.15 ex4-15.txt EX-4.15 25902
4 EXHIBIT 21.1 ex21-1.txt EX-21.1 2554
5 EXHIBIT 23.1 ex23-1.txt EX-23.1 830
  Complete submission text file 0000950116-01-500609.txt   116936
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-67118 | Film No.: 1701363
SIC: 2834 Pharmaceutical Preparations